CAS 1319207-44-7

Fórmula: C20H21Cl2NO6

InChI: InChI=1S/C20H21Cl2NO6/c1-29-10-17(24)23-16(18(25)19(26)20(27)28)6-11-2-4-12(5-3-11)13-7-14(21)9-15(22)8-13/h2-5,7-9,16,18-19,25-26H,6,10H2,1H3,(H,23,24)(H,27,28)/t16-,18-,19+/m0/s1

Clave InChI: NTCBTNCWNRCBGX-YTQUADARSA-N

SMILES: COCC(=O)N[C@@H](CC1=CC=C(C=C1)C2=CC(=CC(=C2)Cl)Cl)[C@@H]([C@H](C(=O)O)O)O

CC0651

CAS: 1319207-44-7

Pureza: 95%

Ref: IN-DA009CAA

CC0651

CAS: 1319207-44-7

CC0651 is a highly selective allosteric inhibitor of human Cdc34 ubiquitin-conjugating enzyme (UCE), inhibiting p27 Kip1 ubiquitination (IC50=1.72 μM).

Fórmula: C₂₀H₂₁Cl₂NO₆

Pureza: 99.03%

Forma y color: White Solid

Peso molecular: 442.29

Ref: TM-T14896

CC 0651

CAS: 1319207-44-7

CC 0651 is a novel compound that inhibits the enzymes of the ubiquitin-proteasome system by binding to ubiquitin ligases. CC 0651 has been shown to inhibit the enzyme activities of ubiquitin ligases in vitro and in vivo, leading to cancer cell death. This anticancer activity may be due to its ability to inhibit the ubiquitin-proteasome system, which is required for protein degradation and DNA repair. In addition, CC 0651 is a potent inhibitor of lysine residues and is able to cross the cell membrane due to its amide group.

Fórmula: C₂₀H₂₁Cl₂NO₆

Pureza: Min. 95%

Peso molecular: 442.29 g/mol

Ref: 3D-UCC20744